Literature DB >> 1410577

Aggressive treatment of intrathoracic recurrences of thymoma.

A Urgesi1, U Monetti, G Rossi, U Ricardi, G Maggi, G L Sannazzari.   

Abstract

Between 1974 and 1988, 21 patients with intrathoracic recurrences of thymoma received radiotherapy with radical intent; surgery was always attempted when considered feasible: 11 patients were partially (6 cases) or totally (5 cases) resected before irradiation, while in the other 10 radiotherapy was the only treatment. In 7 cases the recurrence was confined to the anterior mediastinum, 9 had pleural nodules without mediastinal lesions and 5 had both mediastinal and pleural lesions. Mediastinal recurrences were treated by opposed parallel mediastinal fields with 2/3 of the dose delivered through the anterior port: doses ranged between 38 and 44 Gy; a boost of 10-16 Gy was given in patients not radically resected. Pleural nodules were treated with a variety of techniques according to the extent of the lesions. The 7-year survival of the whole group was 70%; 5 patients died: 4 with intrathoracic progression and one with distant metastases. The survival was 74% in the 11 patients having received surgery, either radical or subtotal, and 65% in the 10 patients treated with radiotherapy alone: the difference is not significant. Patients with Karnofsky index greater than 70 had a significantly better survival (100%, versus 28%, p = 0.0015). This is a selected series of patients presenting recurrences still amenable to a radical treatment either by surgery and radiotherapy or by radiotherapy alone: the results confirm that an aggressive approach is warranted in patients in good general conditions with recurrences confined to the mediastinum and/or 1 hemithorax.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1410577     DOI: 10.1016/0167-8140(92)90227-l

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  10 in total

1.  Video assisted thoracic surgery (VATS) for recurrent thymoma.

Authors:  Giuseppe Marulli; Giovanni Maria Comacchio; Federico Rea
Journal:  Ann Cardiothorac Surg       Date:  2015-11

Review 2.  Thymoma and thymic carcinoma.

Authors:  Federico Venuta; Erino A Rendina; Marco Anile; Tiziano de Giacomo; Domenico Vitolo; Giorgio F Coloni
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-01-13

Review 3.  Radiotherapy for thymic neoplasms.

Authors:  Clifton D Fuller; Emma H Ramahi; Noel Aherne; Tony Y Eng; Charles R Thomas
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

4.  Thymic neoplasm: a rare disease with a complex clinical presentation.

Authors:  Omar M Rashid; Anthony D Cassano; Kazuaki Takabe
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

5.  Primary chemotherapy with adriamycin, cisplatin, vincristine and cyclophosphamide in locally advanced thymomas: a single institution experience.

Authors:  A Berruti; P Borasio; A Gerbino; G Gorzegno; T Moschini; M Tampellini; F Ardissone; M P Brizzi; A Dolcetti; L Dogliotti
Journal:  Br J Cancer       Date:  1999-11       Impact factor: 7.640

Review 6.  The clinical features, diagnosis and management of recurrent thymoma.

Authors:  Taobo Luo; Hongguang Zhao; Xinming Zhou
Journal:  J Cardiothorac Surg       Date:  2016-08-31       Impact factor: 1.637

7.  The role of salvage radiotherapy in recurrent thymoma.

Authors:  Andrew Jihoon Yang; Seo Hee Choi; Hwa Kyung Byun; Hyun Ju Kim; Chang Geol Lee; Jaeho Cho
Journal:  Radiat Oncol J       Date:  2019-09-30

8.  Optimal management of thymic malignancies: current perspectives.

Authors:  Gabrielle Drevet; Stéphane Collaud; François Tronc; Nicolas Girard; Jean-Michel Maury
Journal:  Cancer Manag Res       Date:  2019-07-22       Impact factor: 3.989

Review 9.  [Treatment of Recurrent Thymoma].

Authors:  Xianping Liu; Xiao Li; Jianfeng Li
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-02-27

10.  Local radiotherapy for pleural dissemination of thymic tumors after initial treatment.

Authors:  Dai Okazaki; Yuta Shibamoto; Takeshi Yanagi; Satoshi Ishikura; Takuhito Kondo; Yuki Yamada; Masanari Niwa
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.